Gingival enlargement is a common clinical feature of gingival and periodontal diseases. It is an unwanted side effect of certain systemic drugs given for nondental treatment. It is being reported with three main groups of drugs like calcium channel blockers (CCBs), immunosuppressants, and anticonvulsants. Among calcium channel blockers, nifedipine causes gingival hyperplasia in about 10% of patients, whereas the incidence of amlodipine-, a third generation calcium channel blocker, induced gingival hyperplasia is very limited. There are very few reports of amlodipine-induced gingival enlargement at a dose of 5 mg. We report a case of amlodipine-induced gingival enlargement in a 45-year-old hypertensive patient taking amlodipine at a dose of 5 mg.
CITATION STYLE
Joshi, S., & Bansal, S. (2013). A Rare Case Report of Amlodipine-Induced Gingival Enlargement and Review of Its Pathogenesis. Case Reports in Dentistry, 2013, 1–3. https://doi.org/10.1155/2013/138248
Mendeley helps you to discover research relevant for your work.